SGLT2 inhibition and cardiovascular outcomes: lessons from recent clinical trials
July 4, 2016
ESC HF 2016 Presentation prepared and held by David Fitchett MD, University of Toronto, Canada at the CME accredited 'Diabetes & Heart Failure: Evaluating novel strategies to address outcomes' held on May 21, 2016 in Florence, Italy.
Unable to login. Invalid email address or password.